Pcdh8 gene suppression critical for zebrafish notochord formation

Can a single protein-encoding gene determine whether a vertebrate embryo develops normally? Yes, according to Osaka Metropolitan University researchers, who found that suppression of Pcdh8 is essential for the notochord to elongate properly in zebrafish.

Graduate School of Medicine Dr. Masatake Kai and Professor Makoto Kondo focused on this paraxial protocadherin (PAPC), which is excluded when dividing cells migrate and form the notochord in the embryo.

In the experiments with zebrafish embryo, when this PAPC is not excluded, the cells do not move to the appropriate location, preventing the notochord from elongating to its proper length. The researchers suggest that the role this gene plays in controlling cell proliferation when expressed might lead to novel tumor therapies in humans.

In this case, the results were obtained using zebrafish, but it is possible that a similar mechanism may also be at work in mammals. We hope to make more progress in understanding the complex mechanisms that give rise to the forms of living things."

Professor Makoto Kondo, Graduate School of Medicine, Osaka Metropolitan University

The findings were published in Scientific Reports.

Source:
Journal reference:

Kai, M., & Kondo, M. (2024). Suppression of Pcdh8/paraxial protocadherin is required for efficient neighbor exchange in morphogenetic cell movement during zebrafish notochord formation. Scientific Reports. doi.org/10.1038/s41598-024-76762-7.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis